Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

FFA has higher long-term remission rates than LPP.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Oral lichen planus is not linked to sex hormone levels.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Sex hormones do not cause oral lichen planus.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eczema and fungal infections are the most common skin problems in Japan, with different age groups and genders affected by various conditions.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Type I interferons play a key role in the development of various skin diseases.